Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0092 | 0.9 |